Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

The National Parkinson Foundation Welcomes New Board Member

MIAMI, FL — The National Parkinson Foundation (NPF) announced the election of Ricardo Caporal to its Board of Directors. 

"We are delighted to welcome Ricardo to NPF’s Board. We are excited about using his entrepreneurial leadership and diverse skill set to make a difference in the lives of the more than one million Americans living with Parkinson’s," stated John W. Kozyak, Esq., NPF Chairman of the Board. “Ricardo has been successful with non-profits, real estate and a wide array of businesses, including music, fashion and technology. You can literally feel Ricardo’s energy and drive and I cannot wait for him to start serving.”

Ricardo Caporal is the Founder & President of Mattoni Group. The Brazil-born property developer has over 10+ years of real estate experience with a history of zest for entrepreneurship in an array of industries including music, fashion, design and technology. Additionally, he has worked in private equity. Caporal’s Mattoni Group real estate investment company includes partnership interests in a diverse portfolio of assets across the Southern part of the United States comprised of rental apartment communities and commercial properties.

Caporal established Mattoni Group in December 2009 with an aim to locate and create unique real estate investment opportunities. With a play on the word Mattoni which means “bricks” in Italian, Caporal’s vision has been to create building blocks by effectively developing and managing the properties under his portfolio so that they revitalize their surrounding communities, attract quality tenants and/or buyers, and produce long-term value. Currently, Mattoni Group handles 1,000+ units in South Florida.

Ricardo is active in local and national organizations and philanthropic causes, including the Young Presidents Organization (YPO) of Miami, where he has served as a member of the board’s Executive Committee.  Caporal graduated Magna Cum Laude and with honors from Babson College with degrees in both entrepreneurship and finance. Caporal was born in Sao Paulo, Brazil and currently lives in Miami, Florida with his wife and two children.

View a complete list of the NPF Board of Directors.

About Parkinson's Disease (PD)
Affecting an estimated one million Americans and four to six million worldwide, PD is the second most common neurodegenerative disease after Alzheimer's and is the 14th leading cause of death in the United States. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression) as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for PD and 60,000 new cases are diagnosed each year in the United States alone.

Wednesday, February 18, 2015
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.

Pages

mail icon

Subscribe to get the latest news on treatments, research and other updates.